Home

To All Vapers/Smokers In Canada. We have acquired over 10,000 signatures on this E-petition  E-1237 ( official petition to government of Canada) We urge all to do their part to insure the consumers voice is heard. We are ready to put forward additional measures to insure consumers are no longer ignored by our elected officials. Thank you all for your support. re:

VIEW PETITION HERE

Canada: Tobacco Harm Reduction Association’s Statement in Favour of Vaping


The THRA opened its statement by explaining the differences between e-cigarettes and HnB devices, adding that despite the fact that vaping products contain no tobacco, they tend to be labelled as tobacco products.

“What are vaping products?

In its simplest form vaping products produce an inhalable vapour which may or may not contain nicotine, as opposed to tobacco products which produce smoke.
This however does not provide a useful definition: There are a growing number of diverse types of vaping product entering the tobacco harm reduction market. These would include, for example: Electronic Liquid Vaporizers (“ELV’s”); Heat not Burn vaporizers (“HnB”) such as IQOS, Ploom and Glo – Tobacco Companies also produce ELV’s
At this point in time there are two types of vapour delivery, ELV’s produced by independent companies and the tobacco industry, and

E-cigarettes as a safer alternatives to cigarettes

The THRA statement then moved on to address the number of concerns associated with vaping products, pointing out that scientific research has shown that e-cigarettes do not contain the deadly substances found in cigarettes and hence they should be considered as safer alternatives.

“Risk Profile of ELV’s.

So far there is no evidence of harm as a result of ELV use. All that exists are two distinct arguments: That ELV products will lead to long term harms and that we do not know enough about ELV’s.  What we do know is that ELV products do not contain the harmful ingredients found in cigarette smoke and on that basis, they are far, far safer than smoking.”

Countless scientific studies in favor of vaping

Subsequently, the statement referred to a number of studies, which clearly indicate that vaping is significantly safer than smoking and should be considered as a harm reduction practice for smokers.

“And now ‘real’ evidence is beginning to emerge. The following refers to a study which is thought to be the first looking at long-term vaping outcomes in “real world” users. The study which assures us of the minimal risk inherent in ELV use and was by researchers from a number of institutions, including University College London, and the Roswell Park Cancer Institute and Centers for Disease Control and Prevention (both in the US).
What is very interesting about this study is the way in which it has been reported. Its weaknesses have been deliberately highlighted:  The audience is clearly informed about recall bias and confounding. You can see this in the UK National Health Service publication, “Long-term vaping ‘far safer than smoking’ says ‘landmark’ study.” (here).
So, it is a landmark study, not just because it was the first of its kind, but because it demonstrates a degree of honesty not to be found in ‘studies’ proclaiming harms from ELV use.
It is the inherent dishonesty / incompetency which is the bedrock for supposed evidence of harm, or the potential for harm, from ELV use.”

Popcorn lung? Formaldehyde? Youth Vaping?

The THRA proceeded to list a number of unsound accusations that have been directed at vaping products, and that are still circulating and informing policy around the world, despite being disproved.

“There has been a tsunami of accusations purporting to be evidence of harm from ELV use. In fact, all it amounts to is wave after wave of headline generating, click-bait rubbish.
Examples of this can be found in the claims that ELV use will lead to:

  • Popcorn lung disease; cancer; heart disease; blindness; lipoid pneumonia, and in one scare story here in Canada, tuberculosis. The list is endless and supported only by studies littered with confounding issues, contradictions, hidden statistics, exaggerations, deliberate deceptions, and demonstrating in some cases, total incompetency;
  • Claims of dangerous levels of formaldehyde where the researchers did not know how to work an ELV device (maybe they did in which case they were lying);
  • Lipoid pneumonia where the doctors thought e liquid was an oil (and failed to spot that the inhaler being used by the patient contained oleic acid}, and;
  • Let us not forget the confusion being created by the classification of a product that contains no tobacco as a tobacco product thereby allowing the claim that tobacco use is increasing among the young – of course it is – when you add vaping to smoking rates, but when taken separately, smoking activity is falling at an unprecedented rate.

And so, it goes on, and it is the role of The Tobacco Harm Reduction Association of Canada (THRA), as with other consumer organizations, to attempt to educate the public so that they can choose a safer alternative to smoking if they so wish.

Heat not Burn Devices

The Harm Reduction Association then turned its attention to HnBs, pointing out that despite not being as safe as e-cigarettes, they are still safer than regular cigarettes, and should therefore be also endorsed as safer alternatives and be made available to those who wish to use them for smoking cessation.

“HnB

The position of THRA with respect to any product there has to be harm reduction.  If a product replaces smoking and is safer than smoking it should be endorsed. However, there are degrees of safety and there are issues pertaining to availability and choice.
That HnB is safer than smoking is not in question. The manufacturers of the products estimate that they are approximately 80% safer than cigarette smoking. The fact that these devices heat tobacco and operate at higher temperatures than ELV’s probably accounts for reduced safety levels in comparison to ELV’s which are estimated to be at least 95% safer by Public Health England.
This being the case, we are dealing with ‘safer’ and ‘safest.’
THRA will not actively promote HnB as things stand because ELV’s are the safest alternative to smoking. But this is not the real issue.
The real issue is consumer choice
Where the tobacco control movement has engaged in some very dubious practices in order to force people to stop smoking, THRA (and others) see it as their mission, not to coerce, bully, harass and terrify smokers through denormalisation programmes, but to inform and to encourage through education: to show people that, if they are smokers, there is a choice: To let people know what these choices are, and this includes HnB products. This is not an endorsement, simply a matter of stating the facts.”

Regulations are still favoring Big Tobacco

The THRA concluded by explaining the current regulatory atmosphere, pointing out that certain countries have created regulations that are making it easy for the tobacco industry to thrive and impossible for the harm reduction-focused vaping industry to truly have a chance to succeed.

“Many vapers worry about the power of the tobacco industry.  They worry that corporate tobacco will use its financial muscle to damage / absorb the small, independent ELV industry – this is normal in any market and it is up to the independents to maintain the highest standards and use the tobacco industry’s inability to create variety against it.  Big Tobacco’s most aggressive moves in the vaping space have yet to come however the stock market’s reaction to the realization as to how deep vaping has cut into Big Tobacco’s current and future market share will hasten a new war on ELV’s.
Choice however is difficult where countries create regulations which favour the tobacco industry. For example, by creating regulations:

  1. Where the cost of compliance is so prohibitive that they can only be met by well capitalized large corporates;
  2. Which restrict innovation, an area where the lumbering tobacco industry is vulnerable; and,
  3. That limit the ability of manufacturers and retailers to deliver accurate information about their products.

Anything that reduces the market or restricts the public’s ability to choose must be countered.”

The THRA stands for Harm Reduction and Honesty

The association emphasized that unlike Tobacco Control organizations it will not stand for the spreading of misinformation and the use of scare tactics, but will promote science-based facts and strive to spread the truth about safer alternatives.

“What THRA will not countenance is the adoption of the language and tactics of Tobacco Control – They are destructive and ultimately self-defeating.
THRA, unlike Tobacco Control, will not resort to the bullying and harassment of smokers in order to make them quit. It will never be guilty of mission creep or allow itself to be ‘bought over’ or ‘captured’ in the way that Tobacco Control and other health agencies have.
THRA stands for honesty, the promotion of science-based policy, and the right for the individual to have choice in his / her search for the best possible lifestyle.”

Diane Caruana – The Vaping Post

INNCO: International Network of Nicotine Consumer Organizations

Nothing About Us Without Us

We are continually  redesigning our website for easier access to information and membership access. For now some of our content may be accessible to members only. Please visit back often as we continually update news and facts on Harm Reduction .

Tobacco harm reduction
(THR) is a public health strategy to lower the health risks associated with using nicotine, as an example of the concept of harm reduction, a strategy for dealing with the abuse of other drugs. Smoking tobacco is widely acknowledged as a leading cause of illness and death. However, nicotine itself is not very harmful, as inferred from the long history of use for nicotine replacement therapy products. Thus, THR measures have been focused on reducing or eliminating the use of combustible tobacco by switching to other nicotine products, including:

  1. Cutting down (either long-term or before quitting smoking)
  2. Temporary abstinence
  3. Switching to non-tobacco nicotine containing products, such as pharmaceutical nicotine replacement therapies or products such as electronic cigarettes ( more favorably called PV’s or personal vaporizer).
  4. Switching to smokeless tobacco products such as Swedish snus
  5. Switching to non-combustible organic or additive-free tobacco products

It is widely acknowledged that discontinuation of all tobacco products confers the greatest lowering of risk. However, approved smoking cessation methods have a 90% failure rate, when used as directed. In addition, there is a considerable population of smokers who are unable or unwilling to achieve abstinence ] Harm reduction is likely of substantial benefit to these smokers and public health. Providing reduced-harm alternatives to smokers is certain to result in lower total population risk than pursuing abstinence-only policies.

The strategy is controversial: proponents of tobacco harm reduction assert that lessening the health risk for the individual user is worthwhile and manifests over the population in fewer tobacco-related illnesses and deaths. Opponents argue that some aspects of harm reduction interfere with cessation and abstinence and might increase initiation.  Source: Wikipedia

We believe based upon  recent clinical studies, research and interventions by professional Tobacco Control Specialist, that the over-all benefit to human suffering demands those opposing THR re-consider their motivation for opposing less harmful products. We further believe modern technology be utilized to significantly decrease such harms to smokers and that promotion of personal vaporizers PV’s or ENDS ( electronic nicotine deliver systems ) as they are referred to by opponents; be considered as a ” primary ” tool for smokers seeking to end their smoking addiction.

Board of Directors  THRA  –  Tobacco Harm Reduction Association of Canada


CALL FOR DOCTORS, HEALTH CARE PROFESSIONALS AND SCIENTISTS IN SUPPORT OF ELECTRONIC CIGARETTES.


As physicians and health professionals we see everyday patients who are severely affected by tobacco smoking, many of whom will eventually die or have their health severely affected despite our help and advice. Tobacco smoking remains the most serious public health issue in the world.
People smoke for the nicotine but die from the chemicals produced when tobacco is burned. Unfortunately, currently available smoking cessation medications have limited efficacy and acceptability for the majority of smokers. However, we believe that there is a solution: the use of electronic cigarettes clearly has huge potential to help many smokers turn their backs on tobacco.

To this end, we strongly believe that ethically and scientifically speaking it is our responsibility to draw attention to the following:

1. It is the combustion of tobacco and the 4000 chemical substances that are produced when smoking cigarettes that are harmful to health of smokers, not the nicotine.

2. The dangers of electronic cigarettes are considerably lower than those of tobacco. From analysis of the constituents of e-cigarette vapour, e-cigarettes can be expected to be at least 95 to 99% safer than smoking tobacco cigarettes in terms of long-term health risks.
3. The vapour exhaled from e-cigarette users is highly unlikely to be harmful to bystanders; nicotine concentrations in exhaled vapour are too low to have pharmacological effects on bystanders.
4. Randomised controlled trials show that e-cigarettes are effective in smoking cessation and studies of the use of e-cigarettes in real world settings show that they are more effective than other means for stopping smoking including Nicotine Replacement Therapy.
5. It is estimated that for every one million people who switch from smoking to electronic cigarettes, some 6000 premature deaths a year would be averted.
6. E-cigarettes do not renormalise smoking. Vaping is not smoking. In many countries the rise in e-cigarette use has been accompanied by a continued decline in tobacco sales and prevalence of smoking.

The characteristics of electronic cigarettes should always be compared to those of conventional cigarettes, and discussion about the absolute long-term safety of electronic cigarettes must be contrasted ethically and scientifically with the absolute certainty of the harmfulness of smoked tobacco.
Already estimated 29m consumers in Europe use e-cigarettes.viii But we believe that the individual and public health gains associated with electronic cigarette use are held back by misconceptions about the product.
In light of the numerous studies undertaken to date we as health professionals cannot remain passive in the face of the clear public health benefits of electronic cigarettes.
We therefore recommend that our colleagues actively learn more about electronic cigarettes as a new public health tool in the ongoing global health campaign against tobacco-related diseases.
We call on our colleagues to sign this declaration in support of the merits of electronic cigarettes based on scientific evidence and ethical debate.

Yours faithfully,
Group of professionals who support this statement.
If you agree with the M.O.V.E statement please click on the image below to add your support.